Events Partner Content Advancing the Next Generation of Microbiome-Based Therapeuti... Join the Microbiome Movement in Asia
Partner Content Partner Content 4 Reasons Why Asia is the Next Hub of Microbiome Innovation Microbiome R&D in Asia-Pacific
News Promethera looks to Asia with €10m investment Belgium-based liver disease specialists Promethera Biosciences have received a leg-up for the Asian market in the form of a €10 million investment from Japanese business conglomerate ITOCHU Corp
News Gilead claims first FDA nod for a hepatitis D therapy At its second attempt, Gilead has won FDA approval for chronic hepatitis D virus drug Hepcludex, four years after it was cleared in the EU.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
